ITE Group PLC
11 January 2008
ITE GROUP PLC
Notification of change in Directors' interests
On 11 January 2008 ITE Group plc granted Contingent Options over the Company's
ordinary shares as follows:
Contingent options were granted to Directors to acquire ordinary shares in the
Company at an exercise price of 1p per share under the terms of, and subject to
the performance and other conditions set out in the ITE Group plc Employees
Performance Share Plan 2004 as set out below:
Bill Dye 267,559
Russell Taylor 158,027
Edward Strachan 24,749
A Contingent Option to acquire ordinary shares in the Company at an exercise
price of 1p per share has been issued under the terms of, and subject to the
performance and other conditions set out in the ITE Group plc Key Contractors'
Performance Share Plan 2004 as set out below:
Edward Strachan 214,047
As set out in the annual report, the vesting of the Contingent Options are
dependent on certain performance targets being met. The performance targets for
these Options are based on aggregate diluted earnings per share figures achieved
over a three year period from 1 October 2007.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.